18348729|t|Can essential fatty acids reduce the burden of disease(s)?
18348729|a|Coronary heart disease, stroke, diabetes mellitus, hypertension, cancer, depression schizophrenia, Alzheimer's disease, and collagen vascular diseases are low-grade systemic inflammatory conditions that are a severe burden on health care resources. Essential fatty acids (EFAs) and their metabolites: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), gamma-linolenic acid (GLA), dihomo-gamma-linolenic acid (DGLA), and arachidonic acid (AA) and their products: prostaglandin E1, prostacyclin, lipoxins, resolvins, and protectins suppress inflammation, augment healing, and are of benefit in the prevention and management of these conditions. Hence, supplementation of EFAs could reduce burden of these disease(s).
18348729	4	25	essential fatty acids	Chemical	MESH:D005228
18348729	59	81	Coronary heart disease	Disease	MESH:D003327
18348729	83	89	stroke	Disease	MESH:D020521
18348729	91	108	diabetes mellitus	Disease	MESH:D003920
18348729	110	122	hypertension	Disease	MESH:D006973
18348729	124	130	cancer	Disease	MESH:D009369
18348729	132	142	depression	Disease	MESH:D003866
18348729	143	156	schizophrenia	Disease	MESH:D012559
18348729	158	177	Alzheimer's disease	Disease	MESH:D000544
18348729	183	209	collagen vascular diseases	Disease	MESH:D014652
18348729	233	256	inflammatory conditions	Disease	MESH:D007249
18348729	308	329	Essential fatty acids	Chemical	MESH:D005228
18348729	331	335	EFAs	Chemical	MESH:D005228
18348729	360	381	eicosapentaenoic acid	Chemical	MESH:D015118
18348729	383	386	EPA	Chemical	MESH:D015118
18348729	389	409	docosahexaenoic acid	Chemical	MESH:D004281
18348729	411	414	DHA	Chemical	MESH:D004281
18348729	417	437	gamma-linolenic acid	Chemical	MESH:D017965
18348729	439	442	GLA	Chemical	MESH:D017965
18348729	445	472	dihomo-gamma-linolenic acid	Chemical	MESH:D015126
18348729	474	478	DGLA	Chemical	MESH:D015126
18348729	485	501	arachidonic acid	Chemical	MESH:D016718
18348729	527	543	prostaglandin E1	Chemical	MESH:D000527
18348729	545	557	prostacyclin	Chemical	MESH:D011464
18348729	559	567	lipoxins	Chemical	MESH:D044045
18348729	569	578	resolvins	Chemical	-
18348729	604	616	inflammation	Disease	MESH:D007249
18348729	734	738	EFAs	Chemical	MESH:D005228
18348729	Negative_Correlation	MESH:D016718	MESH:D007249
18348729	Negative_Correlation	MESH:D015126	MESH:D007249
18348729	Negative_Correlation	MESH:D005228	MESH:D003327
18348729	Negative_Correlation	MESH:D015118	MESH:D007249
18348729	Negative_Correlation	MESH:D005228	MESH:D014652
18348729	Negative_Correlation	MESH:D017965	MESH:D007249
18348729	Negative_Correlation	MESH:D005228	MESH:D003920
18348729	Negative_Correlation	MESH:D005228	MESH:D015126
18348729	Negative_Correlation	MESH:D000527	MESH:D007249
18348729	Negative_Correlation	MESH:D044045	MESH:D007249
18348729	Negative_Correlation	MESH:D005228	MESH:D006973
18348729	Negative_Correlation	MESH:D005228	MESH:D007249
18348729	Negative_Correlation	MESH:D005228	MESH:D020521
18348729	Negative_Correlation	MESH:D004281	MESH:D007249
18348729	Negative_Correlation	MESH:D011464	MESH:D007249

